[1]
G. . Escalada Lesme, “From diabetes to heart failure: sodium-glucose transporter type 2 inhibitors, the new therapeutic option”, Rev. Nac. (Itauguá), vol. 12, no. 2, pp. 130–132, Jul. 2021.